• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子对于通过抑制mTOR来抑制实验性肿瘤生长并非必不可少。

HIF is not essential for suppression of experimental tumor growth by mTOR inhibition.

作者信息

Knaup Karl X, Guenther Regina, Stoeckert Johanna, Monti Juliana M, Eckardt Kai-Uwe, Wiesener Michael S

机构信息

Department of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.

出版信息

J Cancer. 2017 Jul 1;8(10):1809-1817. doi: 10.7150/jca.16486. eCollection 2017.

DOI:10.7150/jca.16486
PMID:28819378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5556644/
Abstract

The Hypoxia Inducible Transcription Factor (HIF) is the master regulator of cellular response to hypoxic adaptation. Solid tumors inevitably harbour hypoxic regions with subsequent stabilization and activation of HIF and HIF target genes due to poor vascularization and rapid growth. The mammalian target of rapamycin (mTOR) is a global regulator of cellular growth and proliferation, which can also regulate HIF expression independantly of hypoxia via specific activation of cellular translation and transcription. An effective blockade of mTOR results in attenuation of HIF under hypoxic conditions . This mechanism could enable a simultaneous inhibition of both the mTOR- and the HIF-pathway, resulting in an effective tool for cancer targeting. We set out to analyze the effect of mTOR inhibition and the involvement of mTOR regulation on HIF in a subcutaneous xenograft model in nude mice. Our results demonstrate that mTOR inhibition in our model leads to a clear reduction in tumor growth of various cellular origins, most likely due to inhibition of cellular proliferation. Moreover, these effects can also be achieved independently of the HIF status of the tumor cells. The HIF levels seem to remain unaffected by mTOR inhibition, probably due to the profound hypoxic environment in these threedimensional structures, consequently leading to a strong HIF stabillization. Therefore, treatment of these experimental tumors with mTOR inhibitors is an effective tool to achieve size regression. The involvement of and the effect on HIF in this setting is nevertheless negligible.

摘要

缺氧诱导转录因子(HIF)是细胞对缺氧适应反应的主要调节因子。实体瘤不可避免地存在缺氧区域,由于血管生成不良和生长迅速,随后会出现HIF及其靶基因的稳定和激活。雷帕霉素哺乳动物靶点(mTOR)是细胞生长和增殖的全局调节因子,它还可以通过细胞翻译和转录的特异性激活,独立于缺氧调节HIF表达。有效阻断mTOR会导致缺氧条件下HIF减弱。这种机制可以同时抑制mTOR和HIF途径,从而成为一种有效的癌症靶向工具。我们着手分析在裸鼠皮下异种移植模型中mTOR抑制的效果以及mTOR调节对HIF的影响。我们的结果表明,在我们的模型中,mTOR抑制导致各种细胞来源的肿瘤生长明显减少,这很可能是由于细胞增殖受到抑制。此外,这些效果也可以独立于肿瘤细胞的HIF状态实现。HIF水平似乎不受mTOR抑制的影响,这可能是由于这些三维结构中存在严重的缺氧环境,从而导致HIF强烈稳定。因此,用mTOR抑制剂治疗这些实验性肿瘤是实现肿瘤大小缩小的有效工具。然而,在这种情况下,mTOR对HIF的影响可以忽略不计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41aa/5556644/b74773c9db2d/jcav08p1809g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41aa/5556644/d3e888b6e468/jcav08p1809g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41aa/5556644/2cb87bb54041/jcav08p1809g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41aa/5556644/46dc7c92f46e/jcav08p1809g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41aa/5556644/b74773c9db2d/jcav08p1809g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41aa/5556644/d3e888b6e468/jcav08p1809g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41aa/5556644/2cb87bb54041/jcav08p1809g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41aa/5556644/46dc7c92f46e/jcav08p1809g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41aa/5556644/b74773c9db2d/jcav08p1809g004.jpg

相似文献

1
HIF is not essential for suppression of experimental tumor growth by mTOR inhibition.缺氧诱导因子对于通过抑制mTOR来抑制实验性肿瘤生长并非必不可少。
J Cancer. 2017 Jul 1;8(10):1809-1817. doi: 10.7150/jca.16486. eCollection 2017.
2
Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability.缺氧诱导因子与雷帕霉素哺乳动物靶蛋白的相互调节作为氧可用性的函数
Mol Cancer Res. 2009 Jan;7(1):88-98. doi: 10.1158/1541-7786.MCR-08-0288.
3
Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model.雷帕霉素的哺乳动物靶点在人类胃癌中被激活,并在实验模型中作为治疗靶点。
Int J Cancer. 2007 Apr 15;120(8):1803-10. doi: 10.1002/ijc.22442.
4
Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.针对卵巢透明细胞腺癌中mTOR-HIF-1α-VEGF通路的治疗策略
Pathol Int. 2009 Jan;59(1):19-27. doi: 10.1111/j.1440-1827.2008.02320.x.
5
Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways.紫苏醇能有效清除细胞活性氧,并通过mTOR/4E-BP1信号通路抑制缺氧诱导因子-1α的翻译表达。
Int Immunopharmacol. 2016 Oct;39:1-9. doi: 10.1016/j.intimp.2016.06.034. Epub 2016 Jul 6.
6
Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.雷帕霉素通过/mTOR/HIF-1α/VEGF/信号通路抑制缺氧诱导的视网膜色素上皮细胞增殖
IUBMB Life. 2015 Jun;67(6):446-52. doi: 10.1002/iub.1382. Epub 2015 May 19.
7
Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.葫芦素 B 抑制低氧诱导因子-1α 的翻译表达。
Eur J Pharmacol. 2014 Jan 15;723:46-54. doi: 10.1016/j.ejphar.2013.12.005. Epub 2013 Dec 12.
8
Silent Information Regulator 1 Negatively Regulates Atherosclerotic Angiogenesis via Mammalian Target of Rapamycin Complex 1 Signaling Pathway.沉默信息调节因子 1 通过雷帕霉素靶蛋白复合物 1 信号通路负调控动脉粥样硬化血管生成。
Am J Med Sci. 2018 Aug;356(2):168-176. doi: 10.1016/j.amjms.2018.04.010. Epub 2018 Apr 25.
9
Alterations of hypoxia-induced factor signaling pathway due to mammalian target of rapamycin (mTOR) suppression in ovarian clear cell adenocarcinoma: in vivo and in vitro explorations for clinical trial.哺乳动物雷帕霉素靶蛋白(mTOR)抑制导致卵巢透明细胞腺癌缺氧诱导因子信号通路改变:临床试验的体内外探索。
Int J Gynecol Cancer. 2013 Sep;23(7):1210-8. doi: 10.1097/IGC.0b013e31829d2d51.
10
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.厚朴酚通过抑制低氧诱导因子-1α/血管内皮生长因子信号通路抑制人膀胱癌的血管生成。
Biochem Pharmacol. 2013 May 1;85(9):1278-87. doi: 10.1016/j.bcp.2013.02.009. Epub 2013 Feb 14.

引用本文的文献

1
Role of Hypoxia-Associated Long Noncoding RNAs in Cancer Chemo-Therapy Resistance.缺氧相关长链非编码RNA在癌症化疗耐药中的作用
Int J Mol Sci. 2025 Jan 23;26(3):936. doi: 10.3390/ijms26030936.
2
Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia Sensor.缺氧诱导因子缺陷型肿瘤细胞的存活途径:TCA 抑制、过氧化物酶体脂肪酸氧化激活和 AMPK-PGC-1α 缺氧传感器。
Cells. 2022 Nov 14;11(22):3595. doi: 10.3390/cells11223595.
3
HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells.

本文引用的文献

1
mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.mTOR 抑制剂诱导细胞周期停滞并抑制 Epstein-Barr 病毒相关 T 和自然杀伤细胞淋巴瘤细胞的肿瘤生长。
Clin Cancer Res. 2014 Nov 1;20(21):5412-22. doi: 10.1158/1078-0432.CCR-13-3172. Epub 2014 Sep 10.
2
Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.甘替斯匹布阻断 HIF-1 活性并抑制三阴性乳腺癌原位小鼠模型中的肿瘤生长、血管生成、干细胞维持、侵袭和转移。
J Mol Med (Berl). 2014 Feb;92(2):151-64. doi: 10.1007/s00109-013-1102-5. Epub 2013 Nov 20.
3
缺氧肿瘤细胞代谢适应的 HIF-1 非依赖机制。
Cells. 2021 Sep 9;10(9):2371. doi: 10.3390/cells10092371.
4
Mutations in PIK3C2A cause syndromic short stature, skeletal abnormalities, and cataracts associated with ciliary dysfunction.PIK3C2A 基因突变可导致综合征性身材矮小、骨骼异常和白内障,这些异常与纤毛功能障碍有关。
PLoS Genet. 2019 Apr 29;15(4):e1008088. doi: 10.1371/journal.pgen.1008088. eCollection 2019 Apr.
Sustained delivery of a HIF-1 antagonist for ocular neovascularization.
持续递送 HIF-1 拮抗剂治疗眼部新生血管。
J Control Release. 2013 Dec 28;172(3):625-33. doi: 10.1016/j.jconrel.2013.10.008. Epub 2013 Oct 12.
4
The mTOR signalling pathway in human cancer.人类癌症中的mTOR信号通路。
Int J Mol Sci. 2012;13(2):1886-1918. doi: 10.3390/ijms13021886. Epub 2012 Feb 10.
5
Phase I study of temsirolimus in pediatric patients with recurrent/refractory solid tumors.替西罗莫司治疗儿童复发性/难治性实体瘤患者的 I 期研究。
J Clin Oncol. 2011 Jul 20;29(21):2933-40. doi: 10.1200/JCO.2010.33.4649. Epub 2011 Jun 20.
6
Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis.雷帕霉素对结节性硬化症患者血管平滑肌脂肪瘤的影响。
Nefrologia. 2011;31(3):292-8. doi: 10.3265/Nefrologia.pre2011.Apr.10812.
7
Functional regulation of HIF-1α under normoxia--is there more than post-translational regulation?常氧下 HIF-1α 的功能调控——是否不止是翻译后调控?
J Cell Physiol. 2012 Feb;227(2):514-24. doi: 10.1002/jcp.22798.
8
PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells.PTEN 通过依赖和不依赖磷酸酶的机制调节 HepG2 细胞中的血管生成和 VEGF 表达。
Carcinogenesis. 2010 Jul;31(7):1211-9. doi: 10.1093/carcin/bgq085. Epub 2010 Apr 29.
9
The mTOR pathway: a new target in cancer therapy.mTOR 通路:癌症治疗的新靶点。
Curr Cancer Drug Targets. 2010 Aug;10(5):484-95. doi: 10.2174/156800910791517172.
10
Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability.缺氧诱导因子与雷帕霉素哺乳动物靶蛋白的相互调节作为氧可用性的函数
Mol Cancer Res. 2009 Jan;7(1):88-98. doi: 10.1158/1541-7786.MCR-08-0288.